TRANSMEDICS GROUP INC (TMDX)
US89377M1099 - Common Stock
TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
Is TransMedics Group Stock a Buy?
This organ transplant specialist is down, but still has plenty of signs of life.
Down 52%, Is TransMedics Stock a Buy on the Dip?
Sales growth is tapering off for this provider of delivery services for transplant organs.
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)
Why TransMedics Stock Plunged in October
The organ transplant specialist posted disappointing results in its third-quarter report.
1 Top Growth Stock Down 50% to Buy After Its Recent Pullback
TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.
TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving TransMedics...
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
The major indexes declined, but haven't fallen apart.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
RSI Alert: TransMedics Group (TMDX) Now Oversold
TransMedics Stock Crashes After Earnings Disappointment. Time to Load Up the Boat?
Is this the buy-the-dip opportunity investors have been waiting for?
TransMedics, F5 Lead Big After-Hours Earnings Winners, Losers
With earnings season in full swing, big movers abound.
TransMedics Reports Third Quarter 2024 Financial Results
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
Notable Monday Option Activity: HGV, TMDX, FIVE
2 Growth Stocks to Buy Now That Are Flying Under the Radar
Being the leader in their respective markets could make these stocks top performers in the long run.